Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

By | January 10, 2022
Researchers have conducted a retrospective matched case-control study to determine the protection period conferred by the BNT162b2 vaccine on adolescents aged 12 to 16.